Company / Gross Margin
MARAVAI LIFESCIENCES HOLDINGS, INC. Gross Margin History
FY2023-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Gross Margin
18.3%
FY2025
5-year range
18.3% / 48.5%
FY2023-FY2025
Trend
-56.2%
vs FY2024
Sector context
#28 of 28
Health Care
What the data says
Among 28 Health Care companies, MARAVAI LIFESCIENCES HOLDINGS, INC. is in the bottom 0% for gross margin. Declined from 48.5% to 18.3% over the past 2 years.
Based on SEC 10-K filings.
18.3% in FY2025.
Declined from 48.5% to 18.3% over the past 2 years.
Health Care sector context is included.
Gross Margin over time
Growth rates
- 3-Year Change
- -
- 5-Year Change
- -
- 10-Year Change
- -
Sector benchmark
Bottom 0% in Health CareTop 100% of 28This company 18.3% Sector average 60.3%
▼
-69.6% below sector average
Key checks
Key Insights
- In FY2025, gross margin decreased 56.2% year-over-year.
- Currently 42.0pp below the Health Care sector average.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Altman Z-Score -0.22 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Gross MarginValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | 18.3% | -56.2% |
| FY2024 | 41.8% | -13.9% |
| FY2023 | 48.5% | - |
| FY2022 | - | - |
| FY2021 | - | - |
| FY2020 | - | - |
| FY2019 | - | - |
As of FY2025 · SEC 10-K · Updated Feb 28, 2026